S. Colloca

发表

Analysis of T cell responses to chimpanzee adenovirus vectors encoding HIV gag–pol–nef antigen

J. Weber, G. Dickson, R. Tatoud, 2015, Vaccine.

The Kinetics of Hepatitis C Virus-Specific CD8 T-Cell Responses in the Blood Mirror Those in the Liver in Acute Hepatitis C Virus Infection

A. Folgori, R. Cortese, A. Nicosia, 2008, Journal of Virology.

A Novel Adenovirus Type 6 (Ad6)-Based Hepatitis C Virus Vector That Overcomes Preexisting Anti-Ad5 Immunity and Induces Potent and Broad Cellular Immune Responses in Rhesus Macaques

A. Folgori, R. Tafi, A. Meola, 2006, Journal of Virology.

MHC class II invariant chain–adjuvanted viral vectored vaccines enhances T cell responses in humans

A. Folgori, A. Nicosia, P. Klenerman, 2020, Science Translational Medicine.

Chronic hepatitis C viral infection subverts vaccine‐induced T‐cell immunity in humans

A. Folgori, R. Cortese, A. Nicosia, 2016, Hepatology.

Responses to HCV in Man Novel Adenovirus-Based Vaccines Induce Broad and Sustained T Cell

A. Folgori, R. Cortese, A. Nicosia, 2011 .

A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees

A. Folgori, R. Tafi, A. Meola, 2006, Nature Medicine.

Prime-boost vectored malaria vaccines: Progress and prospects

A. Folgori, R. Cortese, A. Nicosia, 2010, Human vaccines.

CRISPR/Cas9-Mediated In Situ Correction of LAMB3 Gene in Keratinocytes Derived from a Junctional Epidermolysis Bullosa Patient.

M. del Río, F. Larcher, F. Cocchiarella, 2018, Molecular therapy : the journal of the American Society of Gene Therapy.

Chimpanzee adenovirus and MVA-vectored respiratory syncytial virus vaccine is safe and expands humoral and cellular immunity in adults

A. Folgori, R. Cortese, A. Nicosia, 2015 .

A novel Chimpanzee serotype-based adenoviral vector as delivery tool for cancer vaccines

R. Cortese, A. Nicosia, G. Ciliberto, 2009, Vaccine.

Site-specific integration mediated by a hybrid adenovirus/adeno-associated virus vector.

R. Cortese, G. Ciliberto, F. Graham, 1999, Proceedings of the National Academy of Sciences of the United States of America.

ChAd63-MVA-vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humans.

R. Cortese, A. Nicosia, R. Sinden, 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

Assessment of novel vaccination regimens using viral vectored liver stage malaria vaccines encoding ME-TRAP

A. Nicosia, S. Faust, A. Lawrie, 2018, Scientific Reports.

Strain-dependent and distinctive T-cell responses to HIV antigens following immunisation of mice with differing chimpanzee adenovirus vaccine vectors

J. Weber, G. Dickson, R. Tatoud, 2016, Vaccine.

Incidence of Hepatitis B virus DNA and DNA-polymerase in sera of Italian asymptomatic carriers with the serological markers of HBV

S. Colloca, G. Carloni, E. Alfani, 2005, Archives of Virology.

Safety and immune response kinetics of GRAd-COV2 vaccine: phase 1 clinical trial results

A. Folgori, A. Bacchieri, C. Agrati, 2022, npj Vaccines.

Phase Ia clinical evaluation of the Plasmodium falciparum blood-stage antigen MSP1 in ChAd63 and MVA vaccine vectors.

R. Cortese, A. Nicosia, A. Lawrie, 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

Therapeutic Vaccine Against Primate Papillomavirus Infections of the Cervix

A. G. Pedersen, A. Folgori, R. Cortese, 2017, Journal of immunotherapy.

Detection of hepatitis B virus DNA in serum using synthetic non-radioactive oligonucleotides.

M. Clementi, A. Manzin, P. Bagnarelli, 1989, Journal of clinical pathology.

Detection of HBV infectivity by spot hybridization in HBeAg‐Negative chronic carriers: HBV DNA in sera from asymptomatic and symptomatic subjects

F. Galibert, M. Clementi, A. Manzin, 1987, Journal of medical virology.

Clinical Assessment of a Recombinant Simian Adenovirus ChAd63: A Potent New Vaccine Vector

A. Folgori, R. Cortese, A. Nicosia, 2012, The Journal of infectious diseases.

Transgene Optimization, Immunogenicity and In Vitro Efficacy of Viral Vectored Vaccines Expressing Two Alleles of Plasmodium falciparum AMA1

A. Holder, A. Hill, S. Draper, 2011, PloS one.

GRAd-COV2, a gorilla adenovirus based candidate vaccine against COVID-19, is safe and immunogenic in young and older adults

A. Folgori, G. Kroemer, C. Agrati, 2021, medRxiv.

4-1BBL Enhances CD8+ T Cell Responses Induced by Vectored Vaccines in Mice but Fails to Improve Immunogenicity in Rhesus Macaques

A. Hill, D. Wyllie, J. Furze, 2014, PloS one.

A high-throughput radiometric assay for hepatitis C virus NS3 protease.

A. Urbani, R. De Francesco, S. Altamura, 1999, Analytical biochemistry.

Modulation of the Immune Response Induced by Gene Electrotransfer of a Hepatitis C Virus DNA Vaccine in Nonhuman Primates

A. Folgori, R. Tafi, A. Meola, 2006, The Journal of Immunology.

Virus DNA Vaccine in Nonhuman Primates by Gene Electrotransfer of a Hepatitis C Modulation of the Immune Response Induced

A. Folgori, R. Tafi, A. Meola, 2006 .

GRAd-COV2 vaccine provides potent and durable immunity in a randomised placebo-controlled phase 2 trial (COVITAR)

A. Folgori, S. Leone, G. Missale, 2022, medRxiv.

Optimising T cell (re)boosting strategies for adenoviral and modified vaccinia Ankara vaccine regimens in humans

A. Folgori, R. Cortese, A. Nicosia, 2020, npj Vaccines.

Fusion of HCV nonstructural antigen to MHC class II-associated invariant chain enhances T-cell responses induced by vectored vaccines in nonhuman primates.

A. Folgori, R. Cortese, A. Nicosia, 2014, Molecular therapy : the journal of the American Society of Gene Therapy.

An Adenovirus Type 5 (Ad5) Amplicon-Based Packaging Cell Line for Production of High-Capacity Helper-Independent ΔE1-E2-E3-E4 Ad5 Vectors

A. Nicosia, G. Ciliberto, D. Catalucci, 2005, Journal of Virology.

Efficient immunization of rhesus macaques with an HCV candidate vaccine by heterologous priming–boosting with novel adenoviral vectors based on different serotypes

A. Folgori, A. Meola, R. Cortese, 2006, Gene Therapy.

Retinal transduction profiles by high-capacity viral vectors

N. Brunetti‐Pierri, B. Davidson, G. Donofrio, 2014, Gene Therapy.

Strong immunogenicity of heterologous prime-boost immunizations with the experimental vaccine GRAd-COV2 and BNT162b2 or ChAdOx1-nCOV19

A. Folgori, C. Agrati, E. Cimini, 2021, npj Vaccines.

Enhanced Vaccine-Induced CD8+ T Cell Responses to Malaria Antigen ME-TRAP by Fusion to MHC Class II Invariant Chain

A. Folgori, R. Cortese, A. Nicosia, 2014, PloS one.

A Genetic Vaccine Encoding Shared Cancer Neoantigens to Treat Tumors with Microsatellite Instability

A. Folgori, A. Nicosia, F. Mori, 2020, Cancer Research.

Efficacy of a virus-vectored vaccine against human and bovine respiratory syncytial virus infections

A. Giuliani, A. Folgori, R. Cortese, 2015, Science Translational Medicine.

Evaluation of the Efficacy of ChAd63-MVA Vectored Vaccines Expressing Circumsporozoite Protein and ME-TRAP Against Controlled Human Malaria Infection in Malaria-Naive Individuals

R. Cortese, A. Nicosia, R. Sinden, 2014, The Journal of infectious diseases.

Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation

A. Folgori, R. Cortese, A. Nicosia, 2013, Nature Communications.

Preventing spontaneous genetic rearrangements in the transgene cassettes of adenovirus vectors

S. Gilbert, S. Colloca, M. Cottingham, 2012, Biotechnology and bioengineering.

Antigen expression determines adenoviral vaccine potency independent of IFN and STING signaling.

Kylie M. Quinn, A. Folgori, R. Cortese, 2015, The Journal of clinical investigation.

A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: First-in-human trial of ChAd63-KH

R. Cortese, P. Kaye, Deborah F. Smith, 2017, PLoS neglected tropical diseases.

Recognition efficiency of the hepatitis B virus polyadenylation signals is tissue specific in transgenic mice

M. Giorgio, M. Tripodi, L. Amicone, 1992, Journal of virology.

Clearance of hepatitis b virus dna and pre‐s surface antigens in patients with markers of acute viral replication

F. Mazzotta, S. Colloca, G. Carloni, 1989, Journal of medical virology.

GRAd-COV2, a gorilla adenovirus-based candidate vaccine against COVID-19, is safe and immunogenic in younger and older adults

A. Folgori, G. Kroemer, C. Agrati, 2021, Science Translational Medicine.

Vaccine Vectors Derived from a Large Collection of Simian Adenoviruses Induce Potent Cellular Immunity Across Multiple Species

A. Folgori, A. Meola, A. Nicosia, 2012, Science Translational Medicine.

Adenoviral vaccine targeting multiple neoantigens as strategy to eradicate large tumors combined with checkpoint blockade

A. Folgori, A. Nicosia, V. Poli, 2019, Nature Communications.

Assessment of novel vaccination regimens using viral vectored liver stage malaria vaccines encoding ME-TRAP

A. Nicosia, S. Faust, A. Lawrie, 2018, Scientific Reports.

Translating the immunogenicity of prime-boost immunization with ChAd63 and MVA ME-TRAP from malaria naive to malaria-endemic populations.

R. Cortese, A. Nicosia, K. Bojang, 2014, Molecular therapy : the journal of the American Society of Gene Therapy.

Safety and Immunogenicity of Heterologous Prime-Boost Immunisation with Plasmodium falciparum Malaria Candidate Vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in Healthy Gambian and Kenyan Adults

R. Cortese, A. Nicosia, K. Bojang, 2013, PloS one.

Construction of an rtTA2s-m2/ttskid-Based transcription regulatory switch that displays no basal activity, good inducibility, and high responsiveness to doxycycline in mice and Non-Human primates

R. Cortese, A. Simon, H. Bujard, 2003 .

Construction of an rtTA2(s)-m2/tts(kid)-based transcription regulatory switch that displays no basal activity, good inducibility, and high responsiveness to doxycycline in mice and non-human primates.

R. Cortese, A. Simon, H. Bujard, 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

Immune responses against a liver-stage malaria antigen induced by simian adenoviral vector AdCh63 and MVA prime-boost immunisation in non-human primates.

A. Folgori, R. Cortese, A. Nicosia, 2010, Vaccine.

Prime-Boost Immunization with Adenoviral and Modified Vaccinia Virus Ankara Vectors Enhances the Durability and Polyfunctionality of Protective Malaria CD8+ T-Cell Responses

R. Cortese, A. Nicosia, A. Hill, 2009, Infection and Immunity.

Chimpanzee adenoviral vectors as vaccines – challenges to move the technology into the fast lane

A. Folgori, A. Nicosia, E. Scarselli, 2017, Expert review of vaccines.

Chimpanzee adenovirus– and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults

Andrew J. Pollard, A. Folgori, R. Cortese, 2015, Science Translational Medicine.

Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge

Mario Roederer, Richard A Koup, Lisa Hensley, 2014, Nature Medicine.

Development of chimpanzee adenoviruses as vaccine vectors: challenges and successes emerging from clinical trials

A. Folgori, R. Cortese, A. Nicosia, 2013, Expert review of vaccines.

Comparative Analysis of the Magnitude, Quality, Phenotype, and Protective Capacity of Simian Immunodeficiency Virus Gag-Specific CD8+ T Cells following Human-, Simian-, and Chimpanzee-Derived Recombinant Adenoviral Vector Immunization

Kylie M. Quinn, B. Moss, A. Folgori, 2013, The Journal of Immunology.

Immunization Recombinant Adenoviral Vector Human-, Simian-, and Chimpanzee-derived T Cells following + Gag-specific Cd8 of Simian Immunodeficiency Virus Quality, Phenotype, and Protective Capacity Comparative Analysis of the Magnitude

A. Folgori, R. Koup, M. Roederer, 2022 .

Novel Adenovirus-Based Vaccines Induce Broad and Sustained T Cell Responses to HCV in Man

A. Folgori, R. Cortese, A. Nicosia, 2012, Science Translational Medicine.

New Candidate Vaccines against Blood-Stage Plasmodium falciparum Malaria: Prime-Boost Immunization Regimens Incorporating Human and Simian Adenoviral Vectors and Poxviral Vectors Expressing an Optimized Antigen Based on Merozoite Surface Protein 1

A. Thomas, A. Holder, J. Wilson, 2011, Infection and Immunity.

Stefano Colloca Induce Potent Cellular Immunity Across Multiple Species Vaccine Vectors Derived from a Large Collection of Simian Adenoviruses

A. Folgori, A. Meola, R. Cortese, 2011 .

A. Thomas, A. Holder, James M. Wilson, 2010, Infection and Immunity.

Vaccine-elicited human T cells recognizing conserved protein regions inhibit HIV-1.

Lucy Dorrell, Nicole Frahm, Josephine Cox, 2014, Molecular therapy : the journal of the American Society of Gene Therapy.

A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA.

Edward Wright, Thomas Strecker, Paul Chaplin, 2015, The New England journal of medicine.

Chimpanzee Adenovirus Vector Ebola Vaccine

J. Mascola, R. Cortese, A. Nicosia, 2017, The New England journal of medicine.

A next generation vaccine against human rabies based on a single dose of a chimpanzee adenovirus vector serotype C

A. Folgori, A. Nicosia, J. Ball, 2020, PLoS neglected tropical diseases.

1051 PHASE I TRIAL OF A HIGHLY IMMUNOGENIC T CELL VACCINE FOR HEPATITIS C VIRUS BASED ON NOVEL ADENOVIRAL VECTORS FROM RARE SEROTYPES

A. Folgori, R. Cortese, A. Nicosia, 2009 .

Highly-Immunogenic Virally-Vectored T-cell Vaccines Cannot Overcome Subversion of the T-cell Response by HCV during Chronic Infection

A. Folgori, R. Cortese, A. Nicosia, 2016, Vaccines.

A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory

Mark M. Davis, A. Folgori, R. Cortese, 2014, Science Translational Medicine.

Differential Screening of Phage-Ab Libraries by Oligonucleotide Microarray Technology

R. Cortese, P. Monaci, A. Nicosia, 2008, PloS one.

Vaccination to Conserved Influenza Antigens in Mice Using a Novel Simian Adenovirus Vector, PanAd3, Derived from the Bonobo Pan paniscus

R. Cortese, A. Nicosia, Mark R. Soboleski, 2013, PloS one.

Combined Adenovirus Vector and Hepatitis C Virus Envelope Protein Prime-Boost Regimen Elicits T Cell and Neutralizing Antibody Immune Responses

A. Folgori, R. Cortese, A. Nicosia, 2014, Journal of Virology.

Antibody Immune Responses Regimen Elicits T Cell and Neutralizing C Virus Envelope Protein Prime-Boost Combined Adenovirus Vector and Hepatitis

A. Folgori, R. Cortese, A. Nicosia, 2014 .

Prime-boost regimens with adjuvanted synthetic long peptides elicit T cells and antibodies to conserved regions of HIV-1 in macaques

A. Nicosia, D. Montefiori, J. Drijfhout, 2012, AIDS.

Long peptides induce polyfunctional T cells against conserved regions of HIV‐1 with superior breadth to single‐gene vaccines in macaques

A. Nicosia, C. Melief, A. McMichael, 2010, European journal of immunology.

Adenoviral vaccine targeting multiple neoantigens as strategy to eradicate large tumors combined with checkpoint blockade

A. Folgori, A. Nicosia, V. Poli, 2019, Nature Communications.

Mucosal Vaccination with Heterologous Viral Vectored Vaccine Targeting Subdominant SIV Accessory Antigens Strongly Inhibits Early Viral Replication

B. Jensen, A. Folgori, R. Cortese, 2017, EBioMedicine.

Phase Ia Clinical Evaluation of the Safety and Immunogenicity of the Plasmodium falciparum Blood-Stage Antigen AMA1 in ChAd63 and MVA Vaccine Vectors

R. Cortese, A. Nicosia, A. Lawrie, 2012, PloS one.

Mucosal delivery of a vectored RSV vaccine is safe and elicits protective immunity in rodents and nonhuman primates

A. Folgori, R. Cortese, A. Nicosia, 2015, Molecular therapy. Methods & clinical development.

Leo Swadling memory vectors that primes , boosts , and sustains functional HCV-specific T cell A human vaccine strategy based on chimpanzee adenoviral and MVA

Mark M. Davis, A. Folgori, R. Cortese, 2014 .

Combination recombinant simian or chimpanzee adenoviral vectors for vaccine development.

J. Mascola, G. Nabel, J. Gall, 2015, Vaccine.

Efficacy, pharmacokinetics, and safety in the mouse and primate retina of dual AAV vectors for Usher syndrome type 1B

P. Melillo, S. Galimberti, M. Valsecchi, 2023, Molecular therapy. Methods & clinical development.

Immunogenicity of a new gorilla adenovirus vaccine candidate for COVID-19

A. Folgori, J. Ball, C. Castilletti, 2020, bioRxiv.

Correction: A next generation vaccine against human rabies based on a single dose of a chimpanzee adenovirus vector serotype C

A. Folgori, A. Nicosia, J. Ball, 2021, PLoS neglected tropical diseases.

GRAd-COV2 vaccine provides potent and durable humoral and cellular immunity to SARS-CoV-2 in randomized placebo-controlled phase 2 trial

A. Folgori, S. Leone, G. Missale, 2023, Cell reports. Medicine.

Adenovirus Type 4 and 7 Vaccination or Adenovirus Type 4 Respiratory Infection Elicits Minimal Cross-Reactive Antibody Responses to Nonhuman Adenovirus Vaccine Vectors

R. Cortese, A. Nicosia, R. Koup, 2014, Clinical and Vaccine Immunology.

cross-reactive antibody to non-human adenovirus vaccine vectors 2

R. Cortese, A. Nicosia, Stephen J. Thomas, 2014 .

Adenovirus DNA Polymerase Loses Fidelity on a Stretch of Eleven Homocytidines during Pre-GMP Vaccine Preparation

T. Hanke, S. Di Marco, S. Colloca, 2022, Vaccines.

Effect of HIV-1 envelope cytoplasmic tail on adenovirus primed virus encoded virus-like particle immunizations.

A. Folgori, D. Montefiori, C. Labranche, 2016, Vaccine.